[go: up one dir, main page]

AR065989A1 - Metodos y composiciones para el tratamiento de trastornos de la respiracion relacionados con el sueno - Google Patents

Metodos y composiciones para el tratamiento de trastornos de la respiracion relacionados con el sueno

Info

Publication number
AR065989A1
AR065989A1 ARP080101456A ARP080101456A AR065989A1 AR 065989 A1 AR065989 A1 AR 065989A1 AR P080101456 A ARP080101456 A AR P080101456A AR P080101456 A ARP080101456 A AR P080101456A AR 065989 A1 AR065989 A1 AR 065989A1
Authority
AR
Argentina
Prior art keywords
treatment
methods
agent
sound
compositions
Prior art date
Application number
ARP080101456A
Other languages
English (en)
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AR065989A1 publication Critical patent/AR065989A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Métodos para el tratamiento de un trastorno de la respiracion relacionado con el sueno tal como la apnea del sueno obstructiva, que comprende la administracion de O-desmetilvenlafaxina o duloxetina. Reivindicacion 5: El método de acuerdo con lareivindicacion 1, caracterizado porque la O-desmetilvenlafaxina es administrada en forma conjunta con un segundo agente activo, en el que el mencionado segundo agente activo es un mejorador del sueno, un agente que trata la excesiva somnolenciadurante las horas del día, un agente contra la obesidad, o un agente que estabiliza el impulso respiratorio.
ARP080101456A 2007-04-09 2008-04-08 Metodos y composiciones para el tratamiento de trastornos de la respiracion relacionados con el sueno AR065989A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92246607P 2007-04-09 2007-04-09

Publications (1)

Publication Number Publication Date
AR065989A1 true AR065989A1 (es) 2009-07-15

Family

ID=39831524

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080101456A AR065989A1 (es) 2007-04-09 2008-04-08 Metodos y composiciones para el tratamiento de trastornos de la respiracion relacionados con el sueno

Country Status (15)

Country Link
US (3) US20080293823A1 (es)
EP (2) EP2455076A1 (es)
JP (1) JP2010523662A (es)
KR (1) KR20100015923A (es)
CN (1) CN101686955A (es)
AR (1) AR065989A1 (es)
AU (1) AU2008236624A1 (es)
BR (1) BRPI0810159A2 (es)
CA (1) CA2683697C (es)
IL (1) IL201430A0 (es)
MX (1) MX2009010805A (es)
NZ (1) NZ580250A (es)
RU (1) RU2009141168A (es)
TW (1) TW200901956A (es)
WO (1) WO2008124128A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011085256A2 (en) * 2010-01-07 2011-07-14 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
WO2011155797A2 (ko) * 2010-06-10 2011-12-15 동아제약 주식회사 결정형 오-데스메틸벤라팍신의 헤미옥살레이트염, 그의 제조방법 및 그의 약제학적 조성물
SG11202007226UA (en) 2018-01-30 2020-08-28 Apnimed Inc Delaware Methods and compositions for treating sleep apnea
CN118557736A (zh) * 2019-02-08 2024-08-30 布里格姆妇女医院 用于治疗睡眠呼吸暂停的方法和组合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
CA2318920A1 (en) 1998-01-29 1999-08-05 James W. Young Pharmaceutical uses of optically pure (-)-bupropion
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
EP1905757A1 (en) * 1999-04-06 2008-04-02 Sepracor Inc. Derivatives of Venlafaxine and methods of preparing and using the same
WO2000076955A1 (en) * 1999-06-15 2000-12-21 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
AU2005215782B2 (en) * 2004-02-17 2011-04-21 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
JP2008524332A (ja) * 2004-12-20 2008-07-10 コレジウム ファーマシューティカル， インク． 睡眠傷害のための医薬組成物
EP1898921B1 (en) * 2005-06-06 2013-05-01 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating sleep disorders
WO2007026219A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
NZ579137A (en) * 2007-02-21 2012-05-25 Sunovion Pharmaceuticals Inc Solid forms comprising (-)-o-desmethylvenlafaxine and uses thereof
WO2009023820A1 (en) * 2007-08-16 2009-02-19 Cypress Biosciences, Inc. Improving the tolerability of a serotonin antagonist and a nsri, a snri or a rima by using them in combination

Also Published As

Publication number Publication date
BRPI0810159A2 (pt) 2014-12-30
CA2683697A1 (en) 2008-10-16
IL201430A0 (en) 2010-05-31
WO2008124128A2 (en) 2008-10-16
WO2008124128A3 (en) 2009-05-07
US20120238616A1 (en) 2012-09-20
MX2009010805A (es) 2009-10-29
KR20100015923A (ko) 2010-02-12
AU2008236624A1 (en) 2008-10-16
JP2010523662A (ja) 2010-07-15
NZ580250A (en) 2012-05-25
RU2009141168A (ru) 2011-05-20
US20150196531A1 (en) 2015-07-16
US20080293823A1 (en) 2008-11-27
CA2683697C (en) 2016-08-16
TW200901956A (en) 2009-01-16
EP2142183A2 (en) 2010-01-13
CN101686955A (zh) 2010-03-31
EP2455076A1 (en) 2012-05-23

Similar Documents

Publication Publication Date Title
GEP20227366B (en) Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
PH12019502427A1 (en) Methods and compositions for treating sleep apnea
BRPI0507224A (pt) método e dispositivo para o tratamento da apnéia obstrutiva do sono e do ronco
MY160894A (en) Oligosaccharide composition for treating skin diseases
IL201479A (en) Use of tapentadol for the preparation of pain medication
NZ606825A (en) Methods and compositions for treating complement-associated disorders
HK1167641A1 (en) 4-hydroxybutyric acid analogs 4-
PH12013500808A1 (en) Pharmaceutical combinations for the treatment of metabolic disorders
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
TW200719882A (en) Treatment of connective tissue diseases of the skin
UA98136C2 (ru) Применение аклидиния для лечения респираторных заболеваний
EA201590933A1 (ru) Новые перорально биодоступные соединения, модулирующие контроль дыхания, и способы их использования
NZ582284A (en) Carbamoyl-cyclohexanes for treating acute mania
AR065989A1 (es) Metodos y composiciones para el tratamiento de trastornos de la respiracion relacionados con el sueno
BRPI0509210A (pt) uso de gaboxadol, e, métodos para tratar função respiratória enfraquecida, e apnéia do sono
NZ607900A (en) Compound composition for inhalation used for treating asthma
JOP20210121A1 (ar) عملية لإنتاج أشكال جرعة صيدلانية تحتوي على مثبطات قناة task-1 و task-3، واستخدامها في علاج اضطراب التنفس
WO2015061790A3 (en) Genetically-associated chronic obstructive pulmonary disease treatment
MY167553A (en) Layered soft palate support and implantation method
PH12022552763A1 (en) Medical use of daridorexant
JP2010523662A5 (es)
MX2009003676A (es) Compuestos s-nitrosotiol y derivados relacionados.
BR112014030699A2 (pt) implante de deformação de língua
CN201969076U (zh) 带壳聚糖的改性聚乳酸抗粘连生物膜
AR048460A1 (es) Tratamiento de la funcion respiratoria alterada con gaboxadol

Legal Events

Date Code Title Description
FB Suspension of granting procedure